Lundbeck is committed to developing and providing innovative, specialty therapies for people with disorders of the central nervous system (CNS), including those with rare diseases. Offering effective therapies is a fundamental component of our commitment to help improve the lives of people with challenging, unmet medical needs. Lundbeck’s work also extends beyond therapeutic solutions. We reach out and work closely with the professional and advocacy communities that inform and support advancing treatment for complex CNS disorders. This close community engagement uniquely augments the meaningful difference we can make in the lives of the patients we serve.

With a robust portfolio of high-need therapies, and a pipeline of promising new drugs, Lundbeck is one of the fastest-growing pharmaceutical companies in the United States.

Our parent company, H. Lundbeck A/S, was founded in 1915 in Copenhagen, Denmark, and today does business in more than 90 markets across the world. Our unique ownership structure allows the company to impact life science research far beyond our own work. The company is 70 percent owned by the Lundbeck Foundation, which contributes millions of dollars each year to scientific research ($71 million in 2010 alone). Research has, in fact, formed the foundation of Lundbeck for more than 50 years, and the company routinely invests more than 20 percent of its annual revenues in research and development.

Although Lundbeck has expanded and evolved significantly since the company’s founding in 1915, today we remain connected to our deep heritage in addressing CNS disorders and driving innovation in often overlooked areas of health care. Our founder’s commitment to making life better for patients drives the work of today’s Lundbeck team members, who have joined us because they have a passion for making a meaningful difference in the lives of others.

It is our steadfast commitment to innovation in the CNS field, our dedication to cutting-edge research, and our active engagement with professional and advocacy organizations that truly sets Lundbeck apart in the pharmaceutical industry. With our ability to efficiently and effectively bring new specialty products to market, and our robust late-stage CNS pipeline, we look forward to a long and bright future of improving the lives of patients in our communities.